[1] AMLASHI F G,TRITOS N A.Thyrotropin-secreting pituitary adenomas:epidemiology,diagnosis,and management[J].Endocrine,2016,52(3):427-440.
[2] 张光涛,姚广明,王楠,等.垂体瘤内镜与显微手术全切除率及内分泌恢复情况的Meta分析[J].中华显微外科杂志,2015,38(4):328-335.
[3] 董楠,王伟杰,方大钊.垂体瘤侵袭性与术后复发的关系研究[J].现代医学,2013,23(25):100-102.
[4] LAMPICHLER K,FERRER P,VILA G,et al.The role of proto-oncogene GLI1 in pituitary adenoma formation and cell survival regulation[J].Endocr Relat Cancer,2015,22(5):793-803.
[5] 张铁辉,李佳,赵冰海,等.垂体瘤转化基因在垂体细胞衰老和垂体瘤生成中机制的研究[J].中国医药导报,2015,12(15):7-11.
[6] MEI C M,LEE L H,YANG X,et al.HEPN1,a novel gene that is frequently down-regulated in hepatocellular carcinoma,suppresses cell growth and induces apoptosis in HepG2 cells[J].J Hepatol,2003,39(4):580-586.
[7] HU P,FAN J P,WU J,et al.Silencing of HEPN1 is responsible for the aggressive biological behavior of pituitary somatotroph adenomas[J].Cell Physiol Biochem,2013,31(2-3):379-388.
[8] 董雅洁,高维娟.Bcl-2、bax、caspase-3在细胞凋亡中的作用及其关系[J].中国老年学杂志,2012,32(21):4828-4830.
[9] JIANG H,ZHAO P J,SU D.Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo[J].Mol Med Rep,2014,9(6):2265-2272.
[10] 王彤,刘存志,刘玉珍.Bcl-2/bax基因调控机体细胞凋亡的机制研究进展[J].中国老年学杂志,2008,28(16):1658-1660. |